PATENT CLAIM ANALYSIS

Application Number: 15896761
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "190100"]

Abstract:
The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as  Acinetobacter  and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.

Claim (Index 34):
The vaccine composition according to  claim 1 , further comprising a delivery vehicle.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.525
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15895511', '15896711', '15896791', '15427976', '14362058']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8539498380712822
- 35 USC 102 Novelty (BERT): 0.6433844138433512
- Combined Prediction Score: 0.8328932956484891
- Mean Citation Score: 676.077222
- Max Citation Score: 719.25415
- Similarity Product: 568.1124909870744

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test